Two B Vitamins Could Cut Your Ulcerative Colitis Risk by Nearly Half, Study Finds

Folate and vitamin B1 might do more than support basic cell function. A new case-control study published in the European Journal of Gastroenterology & Hepatology suggests that people with higher dietary intake of these two B vitamins are significantly less likely to develop ulcerative colitis (UC), a chronic inflammatory bowel disease. The finding is preliminary and needs replication, but it opens a genuinely new line of inquiry into whether what you eat might shape your susceptibility to a disease that affects hundreds of thousands of Americans.

Folate and Vitamin B1 Each Independently Reduce UC Risk

The study, led by Miyake Y and colleagues, found that participants in the highest quartile of dietary folate intake had 40% lower odds of being diagnosed with UC compared to those in the lowest quartile, with an adjusted odds ratio of 0.60 (95% CI: 0.39 to 0.91, P for trend = 0.009). The signal for vitamin B1, also known as thiamine, was even stronger: those with the highest intake had 46% lower odds of UC, with an adjusted odds ratio of 0.54 (95% CI: 0.36 to 0.81, P for trend = 0.004). Both associations held up after accounting for confounders including sex, age, smoking, alcohol use, appendicitis history, family history of UC, education level, and BMI.

Notably, the other three B vitamins examined, specifically B12, B6, and B2, showed no independent association with UC risk. That specificity is part of what makes the finding interesting: this is not a blanket story about B vitamins in general, but about two particular nutrients with distinct biological roles. Folate is essential for DNA synthesis and methylation; thiamine is a key cofactor in energy metabolism and nerve signaling. Animal research on B vitamins in experimental colitis has suggested anti-inflammatory properties across the B group, but human epidemiological evidence pinning down which vitamins matter has been absent until now.

Why These Results Matter for Millions Living with IBD

Ulcerative colitis affects an estimated 600,000 to 900,000 people in the United States, and its long-term consequences can include colorectal cancer, anemia, and bone disease. Current treatments focus on suppressing inflammation rather than preventing the disease from developing in the first place. If dietary patterns, specifically those rich in folate and thiamine, genuinely lower the probability of UC onset, that would be a meaningful addition to public health messaging and potentially to clinical prevention strategies.

Previous research had already hinted at a link between folate and UC. Meta-analyses found lower serum folate levels in UC patients compared to healthy controls, though whether that deficit was a cause or a consequence of the disease remained unclear. This study is the first to look at dietary intake rather than serum levels, and to show an inverse relationship between habitual folate consumption and UC risk. The vitamin B1 finding is newer still, with no prior epidemiological data to compare it against. Separate research has explored B12's role in tissue repair in inflammatory bowel disease, underscoring a growing interest in how individual B vitamins act on the gut at a biological level.

How the Researchers Structured the Study

The team ran a multicenter, hospital-based case-control study in Japan, enrolling 384 UC cases and 665 controls. Cases were limited to patients diagnosed within the previous three years, which reduces the chance that long-standing disease had already altered dietary habits. Dietary intake was measured using a 169-item semi-quantitative food frequency questionnaire, a validated instrument designed to capture habitual consumption patterns rather than recent meals.

Case-control designs are well suited to studying rare or complex diseases because they can efficiently compare many exposures across groups that differ in outcome. The tradeoff is that they are retrospective and observational: they establish correlation, not causation, and they are vulnerable to recall bias (participants may misremember past diet) and selection bias (hospital-based controls may not perfectly represent the general population). The researchers adjusted for a broad set of confounders, but unmeasured variables could still account for some of the observed associations.

Specific Limitations That Temper the Findings

The authors themselves describe their results as exploratory, a label worth taking seriously. The study population was Japanese, and dietary patterns, micronutrient sources, and baseline UC risk all vary across populations, so it is not certain these findings would replicate in European or North American cohorts. The food frequency questionnaire captures averages over time but cannot resolve nutrient timing, cooking methods that affect thiamine content, or whether supplemental vitamins differ from food-derived vitamins in their effect. There is also the broader methodological caution: an odds ratio of 0.54 or 0.60, while notable, does not tell you whether boosting thiamine or folate in a healthy person would actually lower their UC risk. Observational data can generate hypotheses; it cannot confirm them.

That said, the dose-response trend across quartiles for both vitamins, measured by statistically significant P for trend values, is reassuring. A gradient relationship is generally more consistent with a causal interpretation than a simple high-versus-low comparison.

What Researchers Should Test Next

The obvious next step is prospective cohort research: following people over time, measuring diet before any UC diagnosis, and seeing whether those with higher folate and thiamine intake develop UC at lower rates. Mechanistic work is also needed. Folate's role in immune regulation and gut epithelial integrity provides plausible biological pathways, but the exact mechanism linking dietary thiamine to UC susceptibility is not yet understood.

Broader reviews of micronutrient supplementation in inflammatory bowel disease have called for more targeted trials, and this study gives researchers two specific nutrients to prioritize. Whether dietary advice or targeted supplementation could one day form part of a UC prevention strategy depends on that follow-up work. For now, the finding adds folate and vitamin B1 to the list of dietary factors worth investigating seriously in inflammatory bowel disease research.

Evidence rating

EMERGING — 76/100

Caveats:

• Case-control design cannot establish causation — reverse causation is possible if participants changed their diet after symptom onset.
• Dietary intake was self-reported via food frequency questionnaire, which introduces recall and misclassification bias.
• First study to report this specific association; authors describe results as exploratory and note independent validation is required.
• No funding source was disclosed by the authors.

Multicenter hospital-based case-control study (384 UC cases, 665 controls). Demonstrates an inverse association between dietary folate and vitamin B1 intake and UC risk, but case-control design cannot establish causation, and self-reported dietary data introduce measurement error. This is the first study to report these specific associations, and independent replication has not yet been conducted.

References

1. Yoshihiro Miyake, Keiko Tanaka, Chisato Nagata, et al. (2026). Dietary B vitamin intake and risk of ulcerative colitis: a case–control study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000003217
2. Niloufar Dalayeli, Valiollah Hajhashemi, Ardeshir Talebi, Mohsen Minaiyan (2024). Investigating the Impact of Selected B Vitamins (B1, B2, B6, and B12) on Acute Colitis Induced Experimentally in Rats. International Journal of Preventive Medicine. https://doi.org/10.4103/ijpvm.ijpvm_232_23
3. Definition & Facts of Ulcerative Colitis – NIDDK. NIH. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/definition-facts
4. Vitamin B12 promotes cell reprogramming and tissue repair in inflammatory bowel disease. Nature. https://www.nature.com/articles/s42255-023-00910-4
5. Case Control Studies – StatPearls – NCBI Bookshelf – NIH. NIH. https://www.ncbi.nlm.nih.gov/books/NBK567702/
6. Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease – Frontiers. frontiersin.org. https://www.frontiersin.org/articles/10.3389/fphar.2023.1232810/full